REGENXBIO Inc. announced the clearance of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to evaluate RGX-202,...
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, announced the acquisition of intellectual property rights from the...
Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that both in silico and bench testing confirmed that the NextGenPCR PCR reagents detected...
Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb to support its worldwide commercial analytics organization. This agreement...
